APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 2 filers reported holding APPLIED MOLECULAR TRANS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,364,185 | -39.2% | 8,689,075 | -0.1% | 0.71% | -37.5% |
Q2 2023 | $2,243,120 | -37.6% | 8,694,264 | -0.3% | 1.13% | -37.5% |
Q1 2023 | $3,595,287 | -2.4% | 8,721,447 | -0.5% | 1.81% | -9.9% |
Q4 2022 | $3,683,056 | -58.3% | 8,769,181 | -3.3% | 2.01% | -53.8% |
Q3 2022 | $8,825,000 | -66.5% | 9,069,582 | +0.1% | 4.35% | -58.0% |
Q2 2022 | $26,376,000 | -61.5% | 9,063,746 | -0.4% | 10.35% | -44.6% |
Q1 2022 | $68,423,000 | -46.1% | 9,098,780 | +0.3% | 18.70% | -17.0% |
Q4 2021 | $126,875,000 | -45.6% | 9,075,488 | +0.7% | 22.54% | -6.4% |
Q3 2021 | $233,064,000 | -41.9% | 9,009,055 | +2.8% | 24.09% | -42.5% |
Q2 2021 | $400,899,000 | +4.7% | 8,764,720 | +0.8% | 41.88% | -2.0% |
Q1 2021 | $382,793,000 | +43.6% | 8,697,874 | +0.4% | 42.74% | +1.3% |
Q4 2020 | $266,577,000 | -3.3% | 8,663,547 | +0.0% | 42.20% | +7.0% |
Q3 2020 | $275,672,000 | +26.8% | 8,663,466 | +0.2% | 39.44% | +7.7% |
Q2 2020 | $217,401,000 | – | 8,647,640 | – | 36.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EPIQ Capital Group, LLC | 9,098,780 | $68,423,000 | 18.70% |
Founders Fund VI Management, LLC | 826,607 | $6,216,000 | 10.49% |
Founders Fund V Management, LLC | 3,611,615 | $27,159,000 | 1.74% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 320,000 | $2,406,000 | 0.20% |
Avoro Capital Advisors LLC | 1,030,000 | $7,746,000 | 0.14% |
Burleson & Company, LLC | 73,803 | $555,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 71,073 | $534,000 | 0.07% |
Virtus ETF Advisers LLC | 11,621 | $87,000 | 0.04% |
EcoR1 Capital, LLC | 131,693 | $990,000 | 0.03% |
Trexquant Investment LP | 88,445 | $665,000 | 0.03% |